Shanghai Kaibao Pharmaceutical CO.,Ltd (300039.SZ)
CNY 5.88
(-0.34%)
CNY 5.88
(-0.34%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.59 Billion CNY | 42.47% |
| 2022 | 1.11 Billion CNY | 1.66% |
| 2021 | 1.1 Billion CNY | 21.21% |
| 2020 | 908 Million CNY | -36.01% |
| 2019 | 1.41 Billion CNY | -5.44% |
| 2018 | 1.5 Billion CNY | -4.41% |
| 2017 | 1.56 Billion CNY | 4.86% |
| 2016 | 1.49 Billion CNY | 7.26% |
| 2015 | 1.39 Billion CNY | -5.76% |
| 2014 | 1.48 Billion CNY | 11.93% |
| 2013 | 1.32 Billion CNY | 20.07% |
| 2012 | 1.1 Billion CNY | 34.4% |
| 2011 | 819.96 Million CNY | 35.89% |
| 2010 | 603.41 Million CNY | 31.49% |
| 2009 | 458.88 Million CNY | 18.46% |
| 2008 | 387.38 Million CNY | 50.12% |
| 2007 | 258.05 Million CNY | 55.03% |
| 2006 | 166.45 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 292.08 Million CNY | -16.17% |
| 2024 Q2 | 348.43 Million CNY | -26.72% |
| 2024 Q1 | 475.49 Million CNY | 8.14% |
| 2023 Q1 | 459.38 Million CNY | 44.08% |
| 2023 Q4 | 439.72 Million CNY | 42.78% |
| 2023 FY | 1.59 Billion CNY | 42.47% |
| 2023 Q3 | 307.98 Million CNY | -20.41% |
| 2023 Q2 | 386.96 Million CNY | -15.77% |
| 2022 Q4 | 318.83 Million CNY | 22.7% |
| 2022 Q1 | 343.81 Million CNY | 12.5% |
| 2022 Q2 | 196.35 Million CNY | -42.89% |
| 2022 Q3 | 259.84 Million CNY | 32.33% |
| 2022 FY | 1.11 Billion CNY | 1.66% |
| 2021 FY | 1.1 Billion CNY | 21.21% |
| 2021 Q4 | 305.62 Million CNY | 18.96% |
| 2021 Q1 | 339.9 Million CNY | 30.62% |
| 2021 Q3 | 256.9 Million CNY | 29.67% |
| 2021 Q2 | 198.13 Million CNY | -41.71% |
| 2020 Q2 | 182.03 Million CNY | -37.99% |
| 2020 FY | 908 Million CNY | -36.01% |
| 2020 Q4 | 260.22 Million CNY | 51.12% |
| 2020 Q3 | 172.2 Million CNY | -5.4% |
| 2020 Q1 | 293.54 Million CNY | -17.47% |
| 2019 FY | 1.41 Billion CNY | -5.44% |
| 2019 Q4 | 355.66 Million CNY | 29.11% |
| 2019 Q3 | 275.48 Million CNY | -28.96% |
| 2019 Q2 | 387.79 Million CNY | -3.07% |
| 2019 Q1 | 400.08 Million CNY | 14.07% |
| 2018 Q3 | 243.27 Million CNY | -36.93% |
| 2018 FY | 1.5 Billion CNY | -4.41% |
| 2018 Q4 | 350.74 Million CNY | 44.17% |
| 2018 Q1 | 520.89 Million CNY | 64.6% |
| 2018 Q2 | 385.75 Million CNY | -25.94% |
| 2017 Q1 | 457.39 Million CNY | 50.63% |
| 2017 Q3 | 320.19 Million CNY | -32.71% |
| 2017 Q4 | 316.46 Million CNY | -1.16% |
| 2017 FY | 1.56 Billion CNY | 4.86% |
| 2017 Q2 | 475.86 Million CNY | 4.04% |
| 2016 Q1 | 430.74 Million CNY | 72.28% |
| 2016 Q3 | 308.78 Million CNY | -31.98% |
| 2016 Q4 | 303.65 Million CNY | -1.66% |
| 2016 FY | 1.49 Billion CNY | 7.26% |
| 2016 Q2 | 453.96 Million CNY | 5.39% |
| 2015 FY | 1.39 Billion CNY | -5.76% |
| 2015 Q4 | 250.02 Million CNY | -4.92% |
| 2015 Q3 | 262.96 Million CNY | -43.36% |
| 2015 Q2 | 464.3 Million CNY | 10.94% |
| 2015 Q1 | 418.49 Million CNY | 18.61% |
| 2014 Q4 | 352.85 Million CNY | 8.36% |
| 2014 Q3 | 325.63 Million CNY | -22.95% |
| 2014 Q2 | 422.62 Million CNY | 11.23% |
| 2014 FY | 1.48 Billion CNY | 11.93% |
| 2014 Q1 | 379.96 Million CNY | 35.63% |
| 2013 Q1 | 331.97 Million CNY | 33.73% |
| 2013 FY | 1.32 Billion CNY | 20.07% |
| 2013 Q4 | 280.15 Million CNY | -15.28% |
| 2013 Q3 | 330.68 Million CNY | -13.07% |
| 2013 Q2 | 380.4 Million CNY | 14.59% |
| 2012 Q1 | 263.24 Million CNY | 17.73% |
| 2012 Q2 | 302.22 Million CNY | 14.81% |
| 2012 Q3 | 288.28 Million CNY | -4.61% |
| 2012 Q4 | 248.24 Million CNY | -13.89% |
| 2012 FY | 1.1 Billion CNY | 34.4% |
| 2011 Q2 | 208.4 Million CNY | 11.78% |
| 2011 FY | 819.96 Million CNY | 35.89% |
| 2011 Q4 | 223.61 Million CNY | 10.97% |
| 2011 Q1 | 186.43 Million CNY | -4.65% |
| 2011 Q3 | 201.51 Million CNY | -3.31% |
| 2010 Q1 | 108.77 Million CNY | -8.84% |
| 2010 Q4 | 195.52 Million CNY | 13.47% |
| 2010 Q3 | 172.3 Million CNY | 35.88% |
| 2010 FY | 603.41 Million CNY | 31.49% |
| 2010 Q2 | 126.81 Million CNY | 16.59% |
| 2009 Q3 | 121.85 Million CNY | 7.53% |
| 2009 Q4 | 119.31 Million CNY | -2.08% |
| 2009 FY | 458.88 Million CNY | 18.46% |
| 2009 Q2 | 113.32 Million CNY | 8.56% |
| 2009 Q1 | 104.39 Million CNY | -2.61% |
| 2008 Q4 | 107.19 Million CNY | 14.11% |
| 2008 FY | 387.38 Million CNY | 50.12% |
| 2008 Q3 | 93.93 Million CNY | 0.0% |
| 2007 FY | 258.05 Million CNY | 55.03% |
| 2006 FY | 166.45 Million CNY | 0.0% |